Regeneron to Buy 23andMe Out of Bankruptcy for $256 Million by Wallstreet Journal | May 19, 2025 6:05 pm | US Markets Regeneron Pharmaceuticals said it will acquire substantially all assets of the once-sizzling DNA-testing startup.
